BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Skin cancer

1. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. DDB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. PPP6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. HOXC13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. GRIN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. LZTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. NFKB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [